Ownership history in ORBIMED ADVISORS LLC · 20 quarters on record
This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in TERNS PHARMACEUTICALS INC (TERN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 2,153,300 | -5,409,671 | -71.5% | 1.78% | $87.0M | $40.40 |
| 2025 Q3 | UNCHANGED | 7,562,971 | — | 0% | 1.33% | $56.8M | $7.51 |
| 2025 Q2 | UNCHANGED | 7,562,971 | — | 0% | 0.70% | $28.2M | $3.73 |
| 2025 Q1 | UNCHANGED | 7,562,971 | — | 0% | 0.50% | $20.9M | $2.76 |
| 2024 Q4 | UNCHANGED | 7,562,971 | — | 0% | 0.86% | $41.9M | $5.54 |
| 2024 Q3 | REDUCED | 7,562,971 | -56,164 | -0.7% | 1.15% | $63.1M | $8.34 |
| 2024 Q2 | UNCHANGED | 7,619,135 | — | 0% | 1.02% | $51.9M | $6.81 |
| 2024 Q1 | UNCHANGED | 7,619,135 | — | 0% | 0.92% | $50.0M | $6.56 |
| 2023 Q4 | UNCHANGED | 7,619,135 | — | 0% | 0.99% | $49.4M | $6.49 |
| 2023 Q3 | UNCHANGED | 7,619,135 | — | 0% | 0.81% | $38.3M | $5.03 |
As of 2025 Q4 — sorted by position size